Drug recall · September 23, 2015
ClomiPHENE CITRATE Tablets recall
Why: Chemical Contamination: impurity failure due to chemical contamination of the active ingredient.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
ClomiPHENE CITRATE Tablets, USP, 50 mg, 10-count (2 foil sealed plastic trays of 5 tablets each) per carton, Rx only, Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD., Jerusalem, 91010, Israel; Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; NDC 0093-0041-03, UPC 3 0093-0041-03 7.
- Lots / codes
Lot #: 233169, Exp 02/16
- Quantity
- 37,078 cartons
- Company
- EMD Serono, Inc., Rockland, MA
- Distribution
- Nationwide
- Initiated
- September 10, 2015 · Voluntary: Firm initiated
- Classified
- September 15, 2015
- Reported
- September 23, 2015
- Ended
- February 13, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clomiphene
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.